Cagnin Annachiara, Fragiacomo Federica, Camporese Giulia, Turco Matteo, Bussè Cinzia, Ermani Mario, Montagnese Sara
Department of Neurosciences (DNS), University of Padova, Padova, Italy.
IRCCS San Camillo Hospital Foundation, Venice, Italy.
J Alzheimers Dis. 2017;55(4):1529-1536. doi: 10.3233/JAD-160385.
Alterations of the sleep-wake cycle are common features of neurodegenerative dementia.
To study differences in sleep-wake profiles in dementia with Lewy bodies (DLB), Alzheimer's disease (AD), and healthy controls.
30 DLB and 32 AD patients, and 33 healthy elderly participants were studied. Patients were evaluated for global cognitive impairment, extrapyramidal signs, fluctuations of attention, and behavioral disorders. A comprehensive sleep-wake profile was obtained including a set of questionnaires [Pittsburgh Sleep Quality Index (PSQI), REM Sleep Behavior Disorder Single-Question screen (RBD1Q), Epworth Sleepiness Scale (ESS)] and 12-day sleep diaries.
Patients were matched for age, gender, and disease severity. DLB patients showed more severe daytime somnolence/dysfunction due to somnolence, and a higher proportion of RBD-like symptoms (70%) compared to AD and controls (p < 0.001), regardless of the presence of psychoactive drug treatment. As for sleep timing, DLB patients had a greater number of daytime naps and longer night sleep, with the latter being associated with use of clonazepam. The severity of fluctuations was associated with the presence of RBD (Clinician Assessment of Fluctuation score = RBD+: 5.2±3.7; RBD-: 2.1±3.2, p = 0.04). AD patients reported the best sleep-wake profile, while healthy controls declared the poorest sleep quality, although sleep timing and the quality of wakefulness were comparable between AD and controls.
RBD and daytime fluctuations of attention may coexist in DLB and even reciprocally potentiate each other. Self-reports of sleep quality may lead to an underestimation of sleep disturbances in AD, possibly influenced by anosognosia, compared to normal elderly individuals who complain mainly of insomnia.
睡眠-觉醒周期的改变是神经退行性痴呆的常见特征。
研究路易体痴呆(DLB)、阿尔茨海默病(AD)患者与健康对照者在睡眠-觉醒模式上的差异。
对30例DLB患者、32例AD患者和33名健康老年参与者进行研究。对患者进行全面认知功能损害、锥体外系症状、注意力波动及行为障碍的评估。通过一系列问卷[匹兹堡睡眠质量指数(PSQI)、快速眼动睡眠行为障碍单问题筛查(RBD1Q)、爱泼华嗜睡量表(ESS)]及12天的睡眠日记,获得全面的睡眠-觉醒模式信息。
患者在年龄、性别及疾病严重程度方面相匹配。与AD患者及对照者相比,DLB患者因嗜睡导致的日间嗜睡/功能障碍更为严重,且快速眼动睡眠行为障碍样症状的比例更高(70%)(p<0.001),无论是否接受精神活性药物治疗。在睡眠时间方面,DLB患者白天小睡次数更多,夜间睡眠时间更长,后者与使用氯硝西泮有关。波动的严重程度与快速眼动睡眠行为障碍的存在相关(临床波动评估评分=快速眼动睡眠行为障碍阳性:5.2±3.7;快速眼动睡眠行为障碍阴性:2.1±3.2,p=0.04)。AD患者的睡眠-觉醒模式最佳,而健康对照者的睡眠质量最差,尽管AD患者与对照者在睡眠时间及觉醒质量方面相当。
快速眼动睡眠行为障碍与DLB患者的日间注意力波动可能同时存在,甚至相互促进。与主要抱怨失眠的正常老年人相比,AD患者对睡眠质量的自我报告可能会低估睡眠障碍,这可能受到疾病失认症的影响。